DIAMICRON

Glyclazaid is used in the treatment of type II diabetes, i.e. non-insulin-based diabetes, and is used alongside healthy diets and exercise to control high blood sugar.

The treatment is therefore used with caution in the following cases: elderly people.

Malnutrition, irregular dietary diets, eating breaks, fasting periods, or changing diet.

The imbalance between the patient's physical effort and the amount of carbohydrates in the diet.

Problems in kidneys or liver.

Overdose of glyclax plus 80 mg. Some endocrine disorders, such as thyroid disorders, and pitty and adrenal gland deficiency.

Some drugs that increase the risk of hypoglycemic deficiency, such as phenylbutazone (in English: phenylbutazone), use overdose of beta-based pills, such as brupranalol, because they can make warning signs of hypoglasmosis less visible.

Glichlazide, an oral diabetes drug for type II diabetes.

Glichlazeid belongs to the sulfonyl urea drug group.

Glyclazide reduces blood sugar by stimulating the pancreas of beta cells responsible for insulin production, and Glyclazide improves insulin formation immediately after eating, and insulin reduces blood sugar as a response to the diet as it does for people without diabetes.

Glyclyxazeide also affects blood vessels, preventing the collection of bloodbladders and increasing the fracture of blood vaginas, which helps prevent long-term diabetes complications.